Genome-wide copy-number variation study of psychosis in Alzheimer's disease

About 40–60% of patients with late-onset Alzheimer’s disease (AD) develop psychosis, which represents a distinct phenotype of more severe cognitive and functional deficits. The estimated heritability of AD+P is ~61%, which makes it a good target for genetic mapping. We performed a genome-wide copy-number variation (CNV) study on 496 AD cases with psychosis (AD+P), 639 AD subjects with intermediate psychosis (AD intermediate P) and 156 AD subjects without psychosis (AD−P) who were recruited at the University of Pittsburgh Alzheimer's Disease Research Center using over 1 million single-nucleotide polymorphisms (SNPs) and CNV markers. CNV load analysis found no significant difference in total and average CNV length and CNV number in the AD+P or AD intermediate P groups compared with the AD−P group. Our analysis revealed a marginally significant lower number of duplication events in AD+P cases compared with AD−P controls (P=0.059) using multivariable regression model. The most interesting finding was the presence of a genome-wide significant duplication in the APC2 gene on chromosome 19, which was protective against developing AD+P (odds ratio=0.42; P=7.2E−10). We also observed suggestive associations of duplications with AD+P in the SET (P=1.95E−06), JAG2 (P=5.01E−07) and ZFPM1 (P=2.13E−07) genes and marginal association of a deletion in CNTLN (P=8.87E−04). We have identified potential novel loci for psychosis in Alzheimer’s disease that warrant follow-up in large-scale independent studies.

[1]  Richard M Myers,et al.  Population analysis of large copy number variants and hotspots of human genetic disease. , 2009, American journal of human genetics.

[2]  Winnie S. Liang,et al.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. , 2007, Neuron.

[3]  Kk Singh,et al.  An emerging role for Wnt and GSK3 signaling pathways in schizophrenia , 2013, Clinical genetics.

[4]  Ronald C. Petersen,et al.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Alzheimer's & Dementia.

[5]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[6]  H. Clevers,et al.  Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor , 1999, Current Biology.

[7]  F. Westermann,et al.  Novel aphidicolin‐inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene , 2007, Genes, chromosomes & cancer.

[8]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[9]  F. Kuo,et al.  Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor , 1997, Molecular and cellular biology.

[10]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[11]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[12]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[13]  T. Shintani,et al.  Directional Neuronal Migration Is Impaired in Mice Lacking Adenomatous Polyposis Coli 2 , 2012, The Journal of Neuroscience.

[14]  B. Hyman,et al.  Notch Is Expressed in Adult Brain, Is Coexpressed with Presenilin-1, and Is Altered in Alzheimer Disease , 1998, Journal of neuropathology and experimental neurology.

[15]  H. Sakuta,et al.  APC2 Plays an Essential Role in Axonal Projections through the Regulation of Microtubule Stability , 2009, The Journal of Neuroscience.

[16]  N. Rajakumar,et al.  Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum , 2005, Biological Psychiatry.

[17]  M. Gill,et al.  Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.

[18]  Y. Teo,et al.  SgD‐CNV, a database for common and rare copy number variants in three Asian populations , 2011, Human mutation.

[19]  I. Grundke‐Iqbal,et al.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. , 2005, The American journal of pathology.

[20]  J. Wiszniewska,et al.  Olfactory copy number association with age at onset of Alzheimer disease , 2011, Neurology.

[21]  Susanne Walitza,et al.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.

[22]  O L Lopez,et al.  Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I , 2000, Neurology.

[23]  M F Weiner,et al.  The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. , 1995, The American journal of psychiatry.

[24]  Brian Lawlor,et al.  Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms , 2011, Molecular Psychiatry.

[25]  I. Grundke‐Iqbal,et al.  Inhibitors of protein phosphatase-2A: topography and subcellular localization. , 2004, Brain research. Molecular brain research.

[26]  L. Klei,et al.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes , 2011, Neurobiology of Aging.

[27]  H. Ihn,et al.  Identification and characterization of the novel centrosomal protein centlein. , 2008, Biochemical and biophysical research communications.

[28]  J. Vermylen,et al.  Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions , 2002, Human Genetics.

[29]  K. Iqbal,et al.  Involvement of in the abnormal hyperphosphorylation of tau and its reversal by Memantine , 2006 .

[30]  G. Kirov,et al.  A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk , 2012, Human molecular genetics.

[31]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[32]  A. Viale,et al.  Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk , 2013, Front. Genet..

[33]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[34]  I. Grundke‐Iqbal,et al.  Inhibitors of protein phosphatase‐2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau , 2005, FEBS letters.

[35]  A. Bolton,et al.  Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism , 2010, Current genomics.

[36]  K. Nasmyth,et al.  The anaphase promoting complex is required for memory function in mice. , 2010, Learning & memory.

[37]  Li-Huei Tsai,et al.  Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling , 2009, Cell.

[38]  Song Liu,et al.  Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[39]  Sven Cichon,et al.  A genome-wide association study for late-onset Alzheimer's disease using DNA pooling , 2008, BMC Medical Genomics.

[40]  Winnie S. Liang,et al.  GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.

[41]  G. Kyriazis,et al.  Stress-induced Switch in Numb Isoforms Enhances Notch-dependent Expression of Subtype-specific Transient Receptor Potential Channel* , 2009, The Journal of Biological Chemistry.

[42]  Eden R Martin,et al.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.

[43]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[44]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[45]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[46]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[47]  S. Wisniewski,et al.  Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II , 2000, Neurology.

[48]  H. Yao,et al.  The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia , 2005, Molecular Psychiatry.

[49]  Pasko Rakic,et al.  Not(ch) just development: Notch signalling in the adult brain , 2011, Nature Reviews Neuroscience.

[50]  B. Cheyette,et al.  Synaptic Wnt signaling—a contributor to major psychiatric disorders? , 2011, Journal of Neurodevelopmental Disorders.

[51]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[52]  Song Liu,et al.  Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[53]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[54]  J. Javitch,et al.  Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. , 2010, The American journal of psychiatry.

[55]  M A Pericak-Vance,et al.  Genome-wide association study of Alzheimer's disease , 2012, Translational Psychiatry.

[56]  A. Saykin,et al.  Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. , 2012, Current Alzheimer research.

[57]  D. Pinto,et al.  Genome-Wide Survey of Large Rare Copy Number Variants in Alzheimer’s Disease Among Caribbean Hispanics , 2012, G3: Genes | Genomes | Genetics.

[58]  Andrew P. Clark,et al.  Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. , 2013, Genomics.

[59]  Jian-Zhi Wang,et al.  Ser9 phosphorylation causes cytoplasmic detention of I2 PP2A/SET in Alzheimer disease , 2013, Neurobiology of Aging.

[60]  David B Goldstein,et al.  Genome-wide scan of copy number variation in late-onset Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[61]  Claire Paquet,et al.  A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease , 2011, European Journal of Human Genetics.

[62]  Philippe Froguel,et al.  Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. , 2007, Human molecular genetics.

[63]  K. Iqbal,et al.  Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. , 2006, FEBS letters.

[64]  P. Murray,et al.  Psychosis in Alzheimer’s Disease , 2014, Biological Psychiatry.

[65]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[66]  B. Yankner,et al.  Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Fei Liu,et al.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.

[68]  B. Devlin,et al.  Heritability of psychosis in Alzheimer disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.